nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenylephrine—Posterior subcapsular cataract—Prednisolone—ankylosing spondylitis	0.0338	0.0339	CcSEcCtD
Phenylephrine—Corneal thinning—Dexamethasone—ankylosing spondylitis	0.0322	0.0323	CcSEcCtD
Phenylephrine—Corneal thinning—Betamethasone—ankylosing spondylitis	0.0322	0.0323	CcSEcCtD
Phenylephrine—Posterior subcapsular cataract—Betamethasone—ankylosing spondylitis	0.0282	0.0282	CcSEcCtD
Phenylephrine—Posterior subcapsular cataract—Dexamethasone—ankylosing spondylitis	0.0282	0.0282	CcSEcCtD
Phenylephrine—Nerve injury—Prednisolone—ankylosing spondylitis	0.0239	0.024	CcSEcCtD
Phenylephrine—Corneal oedema—Dexamethasone—ankylosing spondylitis	0.0208	0.0209	CcSEcCtD
Phenylephrine—Corneal oedema—Betamethasone—ankylosing spondylitis	0.0208	0.0209	CcSEcCtD
Phenylephrine—Cataract subcapsular—Prednisolone—ankylosing spondylitis	0.02	0.0201	CcSEcCtD
Phenylephrine—Nerve injury—Betamethasone—ankylosing spondylitis	0.02	0.02	CcSEcCtD
Phenylephrine—Nerve injury—Dexamethasone—ankylosing spondylitis	0.02	0.02	CcSEcCtD
Phenylephrine—Vitreous floaters—Dexamethasone—ankylosing spondylitis	0.0192	0.0192	CcSEcCtD
Phenylephrine—Vitreous floaters—Betamethasone—ankylosing spondylitis	0.0192	0.0192	CcSEcCtD
Phenylephrine—Cataract subcapsular—Triamcinolone—ankylosing spondylitis	0.0184	0.0185	CcSEcCtD
Phenylephrine—Cataract subcapsular—Methylprednisolone—ankylosing spondylitis	0.0184	0.0184	CcSEcCtD
Phenylephrine—Nerve injury—Prednisone—ankylosing spondylitis	0.0174	0.0174	CcSEcCtD
Phenylephrine—Eye infection—Prednisolone—ankylosing spondylitis	0.0169	0.0169	CcSEcCtD
Phenylephrine—Cataract subcapsular—Dexamethasone—ankylosing spondylitis	0.0167	0.0167	CcSEcCtD
Phenylephrine—Cataract subcapsular—Betamethasone—ankylosing spondylitis	0.0167	0.0167	CcSEcCtD
Phenylephrine—Cataract subcapsular—Prednisone—ankylosing spondylitis	0.0146	0.0146	CcSEcCtD
Phenylephrine—Hyperaemia—Dexamethasone—ankylosing spondylitis	0.0144	0.0145	CcSEcCtD
Phenylephrine—Hyperaemia—Betamethasone—ankylosing spondylitis	0.0144	0.0145	CcSEcCtD
Phenylephrine—Eye infection—Dexamethasone—ankylosing spondylitis	0.0141	0.0141	CcSEcCtD
Phenylephrine—Eye infection—Betamethasone—ankylosing spondylitis	0.0141	0.0141	CcSEcCtD
Phenylephrine—Intraocular pressure increased—Prednisolone—ankylosing spondylitis	0.0119	0.0119	CcSEcCtD
Phenylephrine—Intraocular pressure increased—Triamcinolone—ankylosing spondylitis	0.0109	0.0109	CcSEcCtD
Phenylephrine—Intraocular pressure increased—Methylprednisolone—ankylosing spondylitis	0.0109	0.0109	CcSEcCtD
Phenylephrine—Intraocular pressure increased—Betamethasone—ankylosing spondylitis	0.00992	0.00993	CcSEcCtD
Phenylephrine—Intraocular pressure increased—Dexamethasone—ankylosing spondylitis	0.00992	0.00993	CcSEcCtD
Phenylephrine—Skin necrosis—Methotrexate—ankylosing spondylitis	0.00909	0.0091	CcSEcCtD
Phenylephrine—Intraocular pressure increased—Prednisone—ankylosing spondylitis	0.00864	0.00865	CcSEcCtD
Phenylephrine—Keratitis—Prednisolone—ankylosing spondylitis	0.00806	0.00807	CcSEcCtD
Phenylephrine—Rales—Methotrexate—ankylosing spondylitis	0.00774	0.00775	CcSEcCtD
Phenylephrine—Keratitis—Dexamethasone—ankylosing spondylitis	0.00673	0.00674	CcSEcCtD
Phenylephrine—Keratitis—Betamethasone—ankylosing spondylitis	0.00673	0.00674	CcSEcCtD
Phenylephrine—Mydriasis—Prednisolone—ankylosing spondylitis	0.00655	0.00657	CcSEcCtD
Phenylephrine—Stinging—Prednisolone—ankylosing spondylitis	0.00645	0.00646	CcSEcCtD
Phenylephrine—Eye irritation—Prednisolone—ankylosing spondylitis	0.00612	0.00613	CcSEcCtD
Phenylephrine—Stinging—Triamcinolone—ankylosing spondylitis	0.00593	0.00594	CcSEcCtD
Phenylephrine—Stinging—Betamethasone—ankylosing spondylitis	0.00538	0.00539	CcSEcCtD
Phenylephrine—Stinging—Dexamethasone—ankylosing spondylitis	0.00538	0.00539	CcSEcCtD
Phenylephrine—Extravasation—Betamethasone—ankylosing spondylitis	0.005	0.00501	CcSEcCtD
Phenylephrine—Extravasation—Dexamethasone—ankylosing spondylitis	0.005	0.00501	CcSEcCtD
Phenylephrine—Pulmonary oedema—Prednisolone—ankylosing spondylitis	0.00465	0.00466	CcSEcCtD
Phenylephrine—Skin exfoliation—Triamcinolone—ankylosing spondylitis	0.00459	0.0046	CcSEcCtD
Phenylephrine—Skin exfoliation—Methylprednisolone—ankylosing spondylitis	0.00458	0.00459	CcSEcCtD
Phenylephrine—Pulmonary oedema—Triamcinolone—ankylosing spondylitis	0.00428	0.00429	CcSEcCtD
Phenylephrine—Pulmonary oedema—Methylprednisolone—ankylosing spondylitis	0.00427	0.00428	CcSEcCtD
Phenylephrine—Skin exfoliation—Betamethasone—ankylosing spondylitis	0.00416	0.00417	CcSEcCtD
Phenylephrine—Skin exfoliation—Dexamethasone—ankylosing spondylitis	0.00416	0.00417	CcSEcCtD
Phenylephrine—Visual disturbance—Prednisolone—ankylosing spondylitis	0.004	0.00401	CcSEcCtD
Phenylephrine—Pulmonary oedema—Dexamethasone—ankylosing spondylitis	0.00388	0.00389	CcSEcCtD
Phenylephrine—Pulmonary oedema—Betamethasone—ankylosing spondylitis	0.00388	0.00389	CcSEcCtD
Phenylephrine—Extravasation—Methotrexate—ankylosing spondylitis	0.00364	0.00365	CcSEcCtD
Phenylephrine—Skin exfoliation—Prednisone—ankylosing spondylitis	0.00363	0.00363	CcSEcCtD
Phenylephrine—Eye pain—Betamethasone—ankylosing spondylitis	0.00351	0.00351	CcSEcCtD
Phenylephrine—Eye pain—Dexamethasone—ankylosing spondylitis	0.00351	0.00351	CcSEcCtD
Phenylephrine—Pulmonary oedema—Prednisone—ankylosing spondylitis	0.00338	0.00339	CcSEcCtD
Phenylephrine—Visual disturbance—Betamethasone—ankylosing spondylitis	0.00334	0.00335	CcSEcCtD
Phenylephrine—Visual disturbance—Dexamethasone—ankylosing spondylitis	0.00334	0.00335	CcSEcCtD
Phenylephrine—Sweating increased—Prednisolone—ankylosing spondylitis	0.00319	0.0032	CcSEcCtD
Phenylephrine—Skin exfoliation—Methotrexate—ankylosing spondylitis	0.00303	0.00304	CcSEcCtD
Phenylephrine—Sweating increased—Triamcinolone—ankylosing spondylitis	0.00294	0.00294	CcSEcCtD
Phenylephrine—Sweating increased—Methylprednisolone—ankylosing spondylitis	0.00293	0.00294	CcSEcCtD
Phenylephrine—Acute coronary syndrome—Prednisolone—ankylosing spondylitis	0.00288	0.00289	CcSEcCtD
Phenylephrine—Myocardial infarction—Prednisolone—ankylosing spondylitis	0.00287	0.00287	CcSEcCtD
Phenylephrine—Pulmonary oedema—Methotrexate—ankylosing spondylitis	0.00283	0.00283	CcSEcCtD
Phenylephrine—Bradycardia—Prednisolone—ankylosing spondylitis	0.00267	0.00268	CcSEcCtD
Phenylephrine—Sweating increased—Dexamethasone—ankylosing spondylitis	0.00267	0.00267	CcSEcCtD
Phenylephrine—Sweating increased—Betamethasone—ankylosing spondylitis	0.00267	0.00267	CcSEcCtD
Phenylephrine—Acute coronary syndrome—Triamcinolone—ankylosing spondylitis	0.00265	0.00266	CcSEcCtD
Phenylephrine—Acute coronary syndrome—Methylprednisolone—ankylosing spondylitis	0.00265	0.00265	CcSEcCtD
Phenylephrine—Myocardial infarction—Triamcinolone—ankylosing spondylitis	0.00264	0.00264	CcSEcCtD
Phenylephrine—Myocardial infarction—Methylprednisolone—ankylosing spondylitis	0.00263	0.00263	CcSEcCtD
Phenylephrine—Visual impairment—Prednisolone—ankylosing spondylitis	0.00253	0.00253	CcSEcCtD
Phenylephrine—Bradycardia—Triamcinolone—ankylosing spondylitis	0.00246	0.00246	CcSEcCtD
Phenylephrine—Bradycardia—Methylprednisolone—ankylosing spondylitis	0.00245	0.00246	CcSEcCtD
Phenylephrine—Visual disturbance—Methotrexate—ankylosing spondylitis	0.00243	0.00244	CcSEcCtD
Phenylephrine—Acute coronary syndrome—Betamethasone—ankylosing spondylitis	0.00241	0.00241	CcSEcCtD
Phenylephrine—Acute coronary syndrome—Dexamethasone—ankylosing spondylitis	0.00241	0.00241	CcSEcCtD
Phenylephrine—Myocardial infarction—Dexamethasone—ankylosing spondylitis	0.00239	0.0024	CcSEcCtD
Phenylephrine—Myocardial infarction—Betamethasone—ankylosing spondylitis	0.00239	0.0024	CcSEcCtD
Phenylephrine—Arrhythmia—Prednisolone—ankylosing spondylitis	0.00235	0.00235	CcSEcCtD
Phenylephrine—Sweating increased—Prednisone—ankylosing spondylitis	0.00232	0.00233	CcSEcCtD
Phenylephrine—Visual impairment—Methylprednisolone—ankylosing spondylitis	0.00232	0.00233	CcSEcCtD
Phenylephrine—Cardiac disorder—Methylprednisolone—ankylosing spondylitis	0.00224	0.00224	CcSEcCtD
Phenylephrine—Bradycardia—Betamethasone—ankylosing spondylitis	0.00223	0.00223	CcSEcCtD
Phenylephrine—Bradycardia—Dexamethasone—ankylosing spondylitis	0.00223	0.00223	CcSEcCtD
Phenylephrine—Angiopathy—Methylprednisolone—ankylosing spondylitis	0.00219	0.00219	CcSEcCtD
Phenylephrine—Immune system disorder—Methylprednisolone—ankylosing spondylitis	0.00218	0.00218	CcSEcCtD
Phenylephrine—Mediastinal disorder—Methylprednisolone—ankylosing spondylitis	0.00217	0.00217	CcSEcCtD
Phenylephrine—Arrhythmia—Triamcinolone—ankylosing spondylitis	0.00216	0.00216	CcSEcCtD
Phenylephrine—Vision blurred—Prednisolone—ankylosing spondylitis	0.00215	0.00216	CcSEcCtD
Phenylephrine—Arrhythmia—Methylprednisolone—ankylosing spondylitis	0.00215	0.00216	CcSEcCtD
Phenylephrine—Visual impairment—Dexamethasone—ankylosing spondylitis	0.00211	0.00211	CcSEcCtD
Phenylephrine—Visual impairment—Betamethasone—ankylosing spondylitis	0.00211	0.00211	CcSEcCtD
Phenylephrine—Mental disorder—Methylprednisolone—ankylosing spondylitis	0.00211	0.00211	CcSEcCtD
Phenylephrine—Acute coronary syndrome—Prednisone—ankylosing spondylitis	0.00209	0.0021	CcSEcCtD
Phenylephrine—Myocardial infarction—Prednisone—ankylosing spondylitis	0.00208	0.00209	CcSEcCtD
Phenylephrine—Dysgeusia—Triamcinolone—ankylosing spondylitis	0.00206	0.00206	CcSEcCtD
Phenylephrine—Syncope—Prednisolone—ankylosing spondylitis	0.00205	0.00205	CcSEcCtD
Phenylephrine—Loss of consciousness—Prednisolone—ankylosing spondylitis	0.00201	0.00201	CcSEcCtD
Phenylephrine—Angiopathy—Betamethasone—ankylosing spondylitis	0.00199	0.00199	CcSEcCtD
Phenylephrine—Angiopathy—Dexamethasone—ankylosing spondylitis	0.00199	0.00199	CcSEcCtD
Phenylephrine—Hypertension—Prednisolone—ankylosing spondylitis	0.00197	0.00198	CcSEcCtD
Phenylephrine—Arrhythmia—Betamethasone—ankylosing spondylitis	0.00196	0.00196	CcSEcCtD
Phenylephrine—Arrhythmia—Dexamethasone—ankylosing spondylitis	0.00196	0.00196	CcSEcCtD
Phenylephrine—Bradycardia—Prednisone—ankylosing spondylitis	0.00194	0.00195	CcSEcCtD
Phenylephrine—Syncope—Triamcinolone—ankylosing spondylitis	0.00188	0.00189	CcSEcCtD
Phenylephrine—Syncope—Methylprednisolone—ankylosing spondylitis	0.00188	0.00188	CcSEcCtD
Phenylephrine—Loss of consciousness—Triamcinolone—ankylosing spondylitis	0.00185	0.00185	CcSEcCtD
Phenylephrine—Loss of consciousness—Methylprednisolone—ankylosing spondylitis	0.00184	0.00185	CcSEcCtD
Phenylephrine—Shock—Prednisolone—ankylosing spondylitis	0.00183	0.00184	CcSEcCtD
Phenylephrine—Tachycardia—Prednisolone—ankylosing spondylitis	0.00182	0.00182	CcSEcCtD
Phenylephrine—Hypertension—Triamcinolone—ankylosing spondylitis	0.00181	0.00182	CcSEcCtD
Phenylephrine—Hypertension—Methylprednisolone—ankylosing spondylitis	0.00181	0.00181	CcSEcCtD
Phenylephrine—Hyperhidrosis—Prednisolone—ankylosing spondylitis	0.0018	0.00181	CcSEcCtD
Phenylephrine—Epinephrine—TNF—ankylosing spondylitis	0.00178	1	CrCbGaD
Phenylephrine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.00177	0.00178	CcSEcCtD
Phenylephrine—Angiopathy—Prednisone—ankylosing spondylitis	0.00173	0.00173	CcSEcCtD
Phenylephrine—Immune system disorder—Prednisone—ankylosing spondylitis	0.00172	0.00173	CcSEcCtD
Phenylephrine—Syncope—Betamethasone—ankylosing spondylitis	0.00171	0.00171	CcSEcCtD
Phenylephrine—Syncope—Dexamethasone—ankylosing spondylitis	0.00171	0.00171	CcSEcCtD
Phenylephrine—Arrhythmia—Prednisone—ankylosing spondylitis	0.0017	0.00171	CcSEcCtD
Phenylephrine—Shock—Triamcinolone—ankylosing spondylitis	0.00169	0.00169	CcSEcCtD
Phenylephrine—Shock—Methylprednisolone—ankylosing spondylitis	0.00168	0.00169	CcSEcCtD
Phenylephrine—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.00168	0.00168	CcSEcCtD
Phenylephrine—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.00168	0.00168	CcSEcCtD
Phenylephrine—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.00168	0.00168	CcSEcCtD
Phenylephrine—Paraesthesia—Prednisolone—ankylosing spondylitis	0.00167	0.00168	CcSEcCtD
Phenylephrine—Tachycardia—Triamcinolone—ankylosing spondylitis	0.00167	0.00168	CcSEcCtD
Phenylephrine—Mental disorder—Prednisone—ankylosing spondylitis	0.00167	0.00167	CcSEcCtD
Phenylephrine—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.00167	0.00167	CcSEcCtD
Phenylephrine—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.00166	0.00167	CcSEcCtD
Phenylephrine—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.00166	0.00166	CcSEcCtD
Phenylephrine—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.00165	0.00166	CcSEcCtD
Phenylephrine—Hypertension—Dexamethasone—ankylosing spondylitis	0.00165	0.00165	CcSEcCtD
Phenylephrine—Hypertension—Betamethasone—ankylosing spondylitis	0.00165	0.00165	CcSEcCtD
Phenylephrine—Pain—Prednisolone—ankylosing spondylitis	0.00159	0.0016	CcSEcCtD
Phenylephrine—Vision blurred—Prednisone—ankylosing spondylitis	0.00156	0.00157	CcSEcCtD
Phenylephrine—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.00154	0.00154	CcSEcCtD
Phenylephrine—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.00154	0.00154	CcSEcCtD
Phenylephrine—Visual impairment—Methotrexate—ankylosing spondylitis	0.00154	0.00154	CcSEcCtD
Phenylephrine—Shock—Betamethasone—ankylosing spondylitis	0.00153	0.00153	CcSEcCtD
Phenylephrine—Shock—Dexamethasone—ankylosing spondylitis	0.00153	0.00153	CcSEcCtD
Phenylephrine—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.00153	0.00153	CcSEcCtD
Phenylephrine—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.00153	0.00153	CcSEcCtD
Phenylephrine—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.00153	0.00153	CcSEcCtD
Phenylephrine—Agitation—Prednisone—ankylosing spondylitis	0.00153	0.00153	CcSEcCtD
Phenylephrine—Tachycardia—Dexamethasone—ankylosing spondylitis	0.00152	0.00152	CcSEcCtD
Phenylephrine—Tachycardia—Betamethasone—ankylosing spondylitis	0.00152	0.00152	CcSEcCtD
Phenylephrine—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.0015	0.00151	CcSEcCtD
Phenylephrine—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.0015	0.00151	CcSEcCtD
Phenylephrine—Syncope—Prednisone—ankylosing spondylitis	0.00149	0.00149	CcSEcCtD
Phenylephrine—Urticaria—Prednisolone—ankylosing spondylitis	0.00148	0.00148	CcSEcCtD
Phenylephrine—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.00148	0.00148	CcSEcCtD
Phenylephrine—Pain—Triamcinolone—ankylosing spondylitis	0.00147	0.00147	CcSEcCtD
Phenylephrine—Loss of consciousness—Prednisone—ankylosing spondylitis	0.00146	0.00146	CcSEcCtD
Phenylephrine—Angiopathy—Methotrexate—ankylosing spondylitis	0.00145	0.00145	CcSEcCtD
Phenylephrine—Immune system disorder—Methotrexate—ankylosing spondylitis	0.00144	0.00144	CcSEcCtD
Phenylephrine—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.00144	0.00144	CcSEcCtD
Phenylephrine—Hypertension—Prednisone—ankylosing spondylitis	0.00143	0.00144	CcSEcCtD
Phenylephrine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.0014	0.00141	CcSEcCtD
Phenylephrine—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.0014	0.0014	CcSEcCtD
Phenylephrine—Paraesthesia—Betamethasone—ankylosing spondylitis	0.0014	0.0014	CcSEcCtD
Phenylephrine—Mental disorder—Methotrexate—ankylosing spondylitis	0.0014	0.0014	CcSEcCtD
Phenylephrine—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.00137	0.00138	CcSEcCtD
Phenylephrine—Urticaria—Triamcinolone—ankylosing spondylitis	0.00136	0.00136	CcSEcCtD
Phenylephrine—Urticaria—Methylprednisolone—ankylosing spondylitis	0.00136	0.00136	CcSEcCtD
Phenylephrine—Dysgeusia—Methotrexate—ankylosing spondylitis	0.00136	0.00136	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.00134	0.00135	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.00134	0.00135	CcSEcCtD
Phenylephrine—Shock—Prednisone—ankylosing spondylitis	0.00133	0.00134	CcSEcCtD
Phenylephrine—Pain—Dexamethasone—ankylosing spondylitis	0.00133	0.00133	CcSEcCtD
Phenylephrine—Pain—Betamethasone—ankylosing spondylitis	0.00133	0.00133	CcSEcCtD
Phenylephrine—Nervous system disorder—Prednisone—ankylosing spondylitis	0.00133	0.00133	CcSEcCtD
Phenylephrine—Tachycardia—Prednisone—ankylosing spondylitis	0.00132	0.00133	CcSEcCtD
Phenylephrine—Skin disorder—Prednisone—ankylosing spondylitis	0.00132	0.00132	CcSEcCtD
Phenylephrine—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.00131	0.00131	CcSEcCtD
Phenylephrine—Vision blurred—Methotrexate—ankylosing spondylitis	0.00131	0.00131	CcSEcCtD
Phenylephrine—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.00126	0.00127	CcSEcCtD
Phenylephrine—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.00126	0.00126	CcSEcCtD
Phenylephrine—Urticaria—Dexamethasone—ankylosing spondylitis	0.00124	0.00124	CcSEcCtD
Phenylephrine—Urticaria—Betamethasone—ankylosing spondylitis	0.00124	0.00124	CcSEcCtD
Phenylephrine—Dizziness—Prednisolone—ankylosing spondylitis	0.00123	0.00124	CcSEcCtD
Phenylephrine—Paraesthesia—Prednisone—ankylosing spondylitis	0.00122	0.00122	CcSEcCtD
Phenylephrine—Pruritus—Triamcinolone—ankylosing spondylitis	0.00121	0.00122	CcSEcCtD
Phenylephrine—Pruritus—Methylprednisolone—ankylosing spondylitis	0.00121	0.00121	CcSEcCtD
Phenylephrine—Chest pain—Methotrexate—ankylosing spondylitis	0.00118	0.00118	CcSEcCtD
Phenylephrine—Rash—Prednisolone—ankylosing spondylitis	0.00118	0.00118	CcSEcCtD
Phenylephrine—Dermatitis—Prednisolone—ankylosing spondylitis	0.00117	0.00118	CcSEcCtD
Phenylephrine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.00117	0.00118	CcSEcCtD
Phenylephrine—Headache—Prednisolone—ankylosing spondylitis	0.00117	0.00117	CcSEcCtD
Phenylephrine—Dizziness—Triamcinolone—ankylosing spondylitis	0.00113	0.00114	CcSEcCtD
Phenylephrine—Dizziness—Methylprednisolone—ankylosing spondylitis	0.00113	0.00113	CcSEcCtD
Phenylephrine—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.00111	0.00111	CcSEcCtD
Phenylephrine—Nausea—Prednisolone—ankylosing spondylitis	0.00111	0.00111	CcSEcCtD
Phenylephrine—Pruritus—Betamethasone—ankylosing spondylitis	0.0011	0.0011	CcSEcCtD
Phenylephrine—Pruritus—Dexamethasone—ankylosing spondylitis	0.0011	0.0011	CcSEcCtD
Phenylephrine—Skin disorder—Methotrexate—ankylosing spondylitis	0.0011	0.0011	CcSEcCtD
Phenylephrine—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.00109	0.0011	CcSEcCtD
Phenylephrine—Vomiting—Triamcinolone—ankylosing spondylitis	0.00109	0.00109	CcSEcCtD
Phenylephrine—Vomiting—Methylprednisolone—ankylosing spondylitis	0.00109	0.00109	CcSEcCtD
Phenylephrine—Rash—Triamcinolone—ankylosing spondylitis	0.00108	0.00108	CcSEcCtD
Phenylephrine—Dermatitis—Triamcinolone—ankylosing spondylitis	0.00108	0.00108	CcSEcCtD
Phenylephrine—Rash—Methylprednisolone—ankylosing spondylitis	0.00108	0.00108	CcSEcCtD
Phenylephrine—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.00108	0.00108	CcSEcCtD
Phenylephrine—Urticaria—Prednisone—ankylosing spondylitis	0.00108	0.00108	CcSEcCtD
Phenylephrine—Headache—Triamcinolone—ankylosing spondylitis	0.00107	0.00108	CcSEcCtD
Phenylephrine—Headache—Methylprednisolone—ankylosing spondylitis	0.00107	0.00107	CcSEcCtD
Phenylephrine—Dizziness—Dexamethasone—ankylosing spondylitis	0.00103	0.00103	CcSEcCtD
Phenylephrine—Dizziness—Betamethasone—ankylosing spondylitis	0.00103	0.00103	CcSEcCtD
Phenylephrine—Nausea—Triamcinolone—ankylosing spondylitis	0.00102	0.00102	CcSEcCtD
Phenylephrine—Paraesthesia—Methotrexate—ankylosing spondylitis	0.00102	0.00102	CcSEcCtD
Phenylephrine—Nausea—Methylprednisolone—ankylosing spondylitis	0.00102	0.00102	CcSEcCtD
Phenylephrine—Dyspnoea—Methotrexate—ankylosing spondylitis	0.00101	0.00101	CcSEcCtD
Phenylephrine—Hypersensitivity—Prednisone—ankylosing spondylitis	0.000998	0.001	CcSEcCtD
Phenylephrine—Vomiting—Betamethasone—ankylosing spondylitis	0.000989	0.000991	CcSEcCtD
Phenylephrine—Vomiting—Dexamethasone—ankylosing spondylitis	0.000989	0.000991	CcSEcCtD
Phenylephrine—Rash—Dexamethasone—ankylosing spondylitis	0.000981	0.000983	CcSEcCtD
Phenylephrine—Rash—Betamethasone—ankylosing spondylitis	0.000981	0.000983	CcSEcCtD
Phenylephrine—Dermatitis—Dexamethasone—ankylosing spondylitis	0.00098	0.000982	CcSEcCtD
Phenylephrine—Dermatitis—Betamethasone—ankylosing spondylitis	0.00098	0.000982	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000978	0.00098	CcSEcCtD
Phenylephrine—Headache—Betamethasone—ankylosing spondylitis	0.000975	0.000977	CcSEcCtD
Phenylephrine—Headache—Dexamethasone—ankylosing spondylitis	0.000975	0.000977	CcSEcCtD
Phenylephrine—Pain—Methotrexate—ankylosing spondylitis	0.000969	0.00097	CcSEcCtD
Phenylephrine—Pruritus—Prednisone—ankylosing spondylitis	0.000959	0.000961	CcSEcCtD
Phenylephrine—Nausea—Betamethasone—ankylosing spondylitis	0.000924	0.000926	CcSEcCtD
Phenylephrine—Nausea—Dexamethasone—ankylosing spondylitis	0.000924	0.000926	CcSEcCtD
Phenylephrine—Urticaria—Methotrexate—ankylosing spondylitis	0.0009	0.000901	CcSEcCtD
Phenylephrine—Dizziness—Prednisone—ankylosing spondylitis	0.000896	0.000898	CcSEcCtD
Phenylephrine—Vomiting—Prednisone—ankylosing spondylitis	0.000862	0.000863	CcSEcCtD
Phenylephrine—Rash—Prednisone—ankylosing spondylitis	0.000855	0.000856	CcSEcCtD
Phenylephrine—Dermatitis—Prednisone—ankylosing spondylitis	0.000854	0.000855	CcSEcCtD
Phenylephrine—Headache—Prednisone—ankylosing spondylitis	0.000849	0.000851	CcSEcCtD
Phenylephrine—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000834	0.000836	CcSEcCtD
Phenylephrine—Nausea—Prednisone—ankylosing spondylitis	0.000805	0.000806	CcSEcCtD
Phenylephrine—Pruritus—Methotrexate—ankylosing spondylitis	0.000801	0.000803	CcSEcCtD
Phenylephrine—Dizziness—Methotrexate—ankylosing spondylitis	0.000749	0.00075	CcSEcCtD
Phenylephrine—Vomiting—Methotrexate—ankylosing spondylitis	0.00072	0.000721	CcSEcCtD
Phenylephrine—Rash—Methotrexate—ankylosing spondylitis	0.000714	0.000715	CcSEcCtD
Phenylephrine—Dermatitis—Methotrexate—ankylosing spondylitis	0.000713	0.000715	CcSEcCtD
Phenylephrine—Headache—Methotrexate—ankylosing spondylitis	0.00071	0.000711	CcSEcCtD
Phenylephrine—Nausea—Methotrexate—ankylosing spondylitis	0.000673	0.000674	CcSEcCtD
